CRAC channels are the primary gateway for calcium to enter immune cells after they detect a threat, and without them the immune system cannot mount an effective response. These channels, formed by a protein called Orai in the cell’s outer membrane and activated by a sensor protein called STIM inside the cell, control everything from T cell activation to the killing of bacteria by white blood cells. Mutations that knock them out cause severe immunodeficiency, while their overactivity has been linked to autoimmune diseases and even cancer spread.
How CRAC Channels Work
The name “CRAC” stands for calcium release-activated calcium channel, which hints at the activation mechanism. When an immune cell encounters a pathogen or receives a signal through its antigen receptor, a signaling cascade depletes calcium from the endoplasmic reticulum, an internal storage compartment. STIM proteins sitting in the membrane of that compartment sense the drop in stored calcium and physically move to spots where the compartment membrane sits close to the cell’s outer membrane. There, STIM reaches across the narrow gap and directly grabs Orai proteins, forcing the channel open and allowing calcium to flood in from outside the cell.1PubMed Central. Store-Operated Calcium Channels
STIM acts as the sensor and the switch, while Orai forms the pore that calcium actually flows through. The channel is extraordinarily selective for calcium over other ions, a feature that gives the cell precise control over downstream signaling.2PubMed Central. Molecular mechanisms of STIM/Orai communication This two-protein system was first postulated over twenty years ago under the general concept of “store-operated calcium entry,” but the molecular identities of STIM and Orai were only pinned down in the mid-2000s through a combination of genetic screens in fruit flies and studies of immunodeficient patients.3PubMed. Capacitative calcium entry: from concept to molecules
The Role in T Cell Activation
T cells are the adaptive arm of the immune system, and CRAC channels are their dominant route for calcium entry after the T cell receptor engages an antigen. That calcium influx is not a minor housekeeping event. It activates a transcription factor called NFAT, which in turn switches on the genes needed for T cells to proliferate, produce cytokines, and differentiate into specialized subtypes such as helper T cells and regulatory T cells. Without adequate calcium flowing through CRAC channels, T cells essentially stall.4PubMed Central. CRAC Channels and Calcium Signaling in T Cell-Mediated Immunity
This dependence is not limited to one flavor of T cell. CRAC channels are required for the function of multiple T cell subsets that provide immunity to infection, drive inflammation, and suppress autoimmunity. That breadth is part of what makes CRAC channel dysfunction so devastating: when the channel fails, the entire adaptive immune response suffers rather than just one corner of it.
Beyond T Cells: Mast Cells, Monocytes, and Phagocytes
Innate immune cells rely on CRAC channels too, though the downstream effects differ by cell type. In mast cells, the cells responsible for allergic reactions and early defense against parasites, calcium entry through CRAC channels drives degranulation, the explosive release of histamine and other inflammatory mediators. Mast cells also release cytokines and chemokines in a calcium-dependent manner, helping to shape the broader immune response that follows.5PubMed. CRAC channels and Ca2+ signaling in mast cells
In monocytes, CRAC channels feed into a different pathway: they control the production of reactive oxygen species, the toxic molecules monocytes use to kill engulfed bacteria. Blocking Orai-mediated calcium entry in human monocytes impairs both oxidative burst and bacterial killing.6PubMed. A calcium-redox feedback loop controls human monocyte immune responses: The role of ORAI Ca2+ channels A similar story plays out during phagocytosis, the process by which immune cells swallow and digest pathogens. Research has shown that after a phagocyte engulfs a bacterium, the oxidative killing inside the phagosome depends on calcium entering through Orai1 and STIM1 and being relayed by calcium-binding proteins called S100A8 and S100A9.7The Journal of Immunology. An Essential Role of STIM1, Orai1, and S100A8āA9 Proteins for Ca2+ Signaling and FcĪ³R-Mediated Phagosomal Oxidative Activity In short, CRAC channels sit at a chokepoint that affects both the alarm-sounding role of innate immunity and its direct killing capacity.
What Happens When CRAC Channels Fail
The most dramatic illustration of CRAC channel importance comes from people born with loss-of-function mutations in the genes encoding Orai1 or STIM1. The resulting condition, called CRAC channelopathy, abolishes store-operated calcium entry and produces a clinical picture that resembles severe combined immunodeficiency. Affected infants suffer recurrent and often life-threatening infections because their T cells cannot activate properly.8PubMed Central. Diseases caused by mutations in ORAI1 and STIM1
Immunodeficiency is not the whole story, though. CRAC channelopathy also causes autoimmunity and abnormal proliferation of lymphocytes, a seemingly paradoxical twist given that the immune system is also weakened. The explanation lies in the fact that regulatory T cells, which suppress misdirected immune attacks on the body’s own tissues, also depend on CRAC channels. When those cells fail alongside the effector cells, the balance tips toward autoimmune damage.9PubMed Central. Immunodeficiency due to mutations in ORAI1 and STIM1
The non-immune features are equally striking. All Orai1-deficient patients studied have shown global muscular hypotonia from birth. Those who survive past infancy, typically after a bone marrow transplant to restore immune function, develop problems including severely defective dental enamel that wears away with normal use, and an inability to sweat, leading to dry skin and heat intolerance.10PubMed Central. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy and ectodermal dysplasia These symptoms make clear that CRAC channels serve important functions in muscle tissue and in skin-related structures like sweat glands and tooth enamel, not just in immune cells.
The Opposite Problem: Gain-of-Function Mutations
If losing CRAC channel function is devastating, having channels that are stuck in the “on” position creates a different set of problems. Gain-of-function mutations in STIM1 or Orai1 cause constitutive calcium entry, meaning calcium pours into cells even when no immune signal has been received. The resulting conditions, tubular aggregate myopathy and Stormorken syndrome, sit on a clinical spectrum and can include muscle weakness, abnormally constricted pupils, low platelet counts with bleeding tendencies, an underactive spleen, dry scaly skin, dyslexia, and short stature.11PubMed. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome
One well-characterized example involves a mutation in the cytoplasmic portion of STIM1 (at position R304W) that causes the protein to act as though stores are always empty, keeping CRAC channels constitutively active. In laboratory models and in zebrafish embryos, this mutation produced spontaneous bleeding and reduced platelet numbers, recapitulating features of Stormorken syndrome.12PubMed Central. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis On the immune side, patients with gain-of-function STIM1 mutations can also show immunological abnormalities, with some developing features that overlap with autoimmune or lymphoproliferative conditions.13PubMed Central. Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement The loss-of-function and gain-of-function syndromes together paint a picture of a system where the amount of calcium entry has to be precisely calibrated. Too little, and immune cells cannot fight infections. Too much, and muscles, blood cells, and other tissues become damaged.
CRAC Channels in Autoimmune and Inflammatory Disease
Beyond the rare inherited mutations, CRAC channel activity appears to be abnormally high in several common autoimmune conditions. In rheumatoid arthritis, researchers found that naĆÆve helper T cells from patients with active disease had increased expression of the CRAC channel protein and correspondingly greater calcium influx compared with healthy controls. Those cells released an abnormal pattern of cytokines, and silencing the CRAC channel gene reversed the abnormal cytokine production.14PubMed. Upregulation of store-operated Ca(2+) entry in the naĆÆve CD4(+) T cells with aberrant cytokine releasing in active rheumatoid arthritis
Inflammatory bowel disease is another area where CRAC channels have drawn attention. Studies using tissue from patients with IBD found that blocking store-operated calcium entry reduced the production of multiple pro-inflammatory cytokines by T cells, innate lymphoid cells, B cells, and myeloid cells isolated from inflamed colon tissue. Importantly, the same treatment did not harm intestinal lining cells, which suggests a degree of selectivity that could be exploited therapeutically.15PubMed Central. Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease In mouse models, deleting CRAC channel genes specifically in T cells produced graded effects: losing Orai1 alone caused a moderate defect in inflammatory T cell function, while losing STIM1 or STIM2 caused progressively more severe impairment, and those defects tracked with progressively milder disease. Direct pharmacological inhibition of CRAC channels also reduced IBD severity in mice.16PubMed Central. Targeting CRAC channels in inflammatory bowel disease
CRAC Channels and Cancer
The connection between CRAC channels and cancer is more complicated than a simple immune story. Tumor cells themselves often overexpress STIM and Orai proteins, and that overexpression correlates with more aggressive disease. Altered CRAC channel function has been reported in breast, prostate, cervical, colorectal, brain, and skin cancers.17PubMed Central. STIM and Orai proteins as novel targets for cancer therapy
In melanoma, the connection is particularly clear. STIM1- and Orai1-mediated calcium oscillations promote invasion by driving the assembly of invadopodia, finger-like structures that tumor cells use to punch through surrounding tissue and enter blood vessels. Knocking down STIM1 in melanoma cells significantly inhibited their ability to metastasize to the lungs in a mouse model.18PubMed Central. STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion More broadly, the overexpression of STIM and Orai proteins has been reported to correlate with the metastatic progression of various cancers, making these channels potential targets not just for immune modulation but for limiting cancer spread.19PubMed Central. The store-operated calcium channels in cancer metastasis: from cell migration, invasion to metastatic colonization
This creates a therapeutic paradox. Blocking CRAC channels might calm autoimmune disease and slow tumor invasion, but it could also weaken the immune system’s ability to fight those same tumors. Any drug targeting this pathway would need to find the right dose or the right delivery strategy to thread that needle.
Built-In Safety Brakes
Cells do not leave CRAC channels wide open indefinitely. A built-in feedback mechanism called slow calcium-dependent inactivation gradually shuts the channels down as calcium accumulates inside the cell. This process can account for up to about 70% of total CRAC channel inactivation, making it the dominant way cells limit calcium entry once channels have been activated.20PubMed. Slow feedback inhibition of calcium release-activated calcium current by calcium entry The inactivation operates through at least two distinct pathways: one involves calcium being pumped back into the endoplasmic reticulum (refilling the store that triggered channel opening in the first place), while the other works independently of store refilling and appears to act on or near the channel itself.21PubMed. Slow calcium-dependent inactivation of depletion-activated calcium current. Store-dependent and -independent mechanisms
A protein called SARAF has been identified as a key player in this slow inactivation process. SARAF interacts with STIM and helps ensure that calcium entry is shut down once the cell has received enough signal. Understanding SARAF has given researchers new molecular insight into how the inactivation process works and has opened additional potential drug targets for situations where calcium entry is pathologically sustained.22PubMed Central. Regulation of Store-Operated Ca(2+) Entry by SARAF
Drug Development Targeting CRAC Channels
The therapeutic potential of CRAC channel blockers is being explored from multiple angles. Researchers studying an anti-Orai1 antibody called DS-2741a found that it suppressed both T cell activation and mast cell degranulation in mice engineered to carry the human version of Orai1, suggesting relevance for both autoimmune and allergic diseases.23PubMed Central. Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation
Small-molecule inhibitors are also in development. Some compounds, such as those developed by GlaxoSmithKline, block Orai1 and Orai3 currents at low micromolar concentrations and appear to act downstream of the STIM-Orai coupling step, likely through an allosteric effect on the channel’s selectivity filter. These blockers do not simply wash out quickly once applied; they show almost no current recovery over several minutes, suggesting a tight and sustained interaction with the channel.24PubMed Central. The action of selective CRAC channel blockers is affected by the Orai pore geometry Another compound, AnCoA4, binds directly to Orai1 at a site in the interface between neighboring subunits, and the binding residues are conserved between the protein used in structural studies and the human version, which is encouraging for translation to people.25Chemistry & Biology. AnCoA4 Inhibits CRAC Channels by Binding to Orai1 and Decreases the Immune Response In Vitro and In Vivo
The furthest along in clinical testing is Auxora (CM4620), a CRAC channel inhibitor that was tested in a phase 2 trial for severe COVID-19 pneumonia. The trial added Auxora to standard care including corticosteroids and measured time to recovery and mortality. Patients who received Auxora had a median recovery time of 7 days compared with 10 days for placebo, though the difference did not reach the conventional threshold for statistical significance. The 30-day mortality rate was lower in the Auxora group, at about 8% versus about 18% for placebo, and that difference was statistically significant.26PubMed Central. Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial The rationale was that excessive calcium entry through CRAC channels was driving the runaway inflammation seen in severe COVID-19 lung injury. These results are encouraging but preliminary; phase 2 trials are designed to signal whether an approach is worth pursuing, not to provide definitive proof.
Evolutionary Roots of the STIM-Orai System
CRAC channels are not a recent evolutionary invention. Database searches have turned up sequences resembling Orai in hyperthermophilic archaea, single-celled organisms that thrive at extreme temperatures and diverged from the lineage leading to animals billions of years ago.27PubMed. Molecular evolution and structural analysis of the Ca(2+) release-activated Ca(2+) channel subunit, Orai Several lineage-specific gene duplications gave rise to the three mammalian Orai proteins (Orai1, Orai2, and Orai3), each with somewhat different properties. Modern Orai proteins appear to have acquired new structural domains around the time of the earliest chordates, before the split into vertebrates, which may explain why fruit fly CRAC currents behave differently from mammalian ones.
STIM proteins have their own evolutionary trajectory, with new signaling domains being added over time as calcium signaling systems became more complex in multicellular organisms.28PubMed Central. Evolutionary origins of STIM1 and STIM2 within ancient Ca2+ signaling systems The deep conservation of both STIM and Orai across the tree of life underscores how fundamental store-operated calcium entry is to cell biology. It is not a specialized trick that immune cells evolved for their own purposes; it is ancient cellular machinery that the immune system has co-opted and refined into a central control mechanism.